Cargando…
Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease
Huntington's disease (HD) is a late-onset and progressive neurodegenerative disorder that is caused by aggregation of mutant huntingtin protein which contains expanded-polyglutamine. The molecular chaperones modulate the aggregation in early stage and known for the most potent protector of neur...
Autores principales: | Kim, Sangjune, Kim, Kyong-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984955/ https://www.ncbi.nlm.nih.gov/pubmed/24737938 http://dx.doi.org/10.5607/en.2014.23.1.36 |
Ejemplares similares
-
Glycogen synthase kinase 3β suppresses polyglutamine aggregation by inhibiting Vaccinia-related kinase 2 activity
por: Lee, Eunju, et al.
Publicado: (2016) -
Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020) -
Molecular Strategies to Target Protein Aggregation in Huntington’s Disease
por: Jarosińska, Olga D., et al.
Publicado: (2021) -
Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006) -
Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016)